← Leaderboards
Alexander Gusev
Harvard School Of Public Health
$6,174,220
Attributed
$13,402,044
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,402,044 · 8
By mechanism
R01$12,471,615 · 5
R56$400,000 · 1
R21$371,891 · 1
F32$158,538 · 1
Top collaborators
- Simon Andrew Gayther5 shared
- Noah A Zaitlen5 shared
- Matthew L Freedman4 shared
- Alexander Gimelbrant4 shared
- Alkes L Price3 shared
- Soumya Raychaudhuri3 shared
- Toni Choueiri2 shared
Most similar at Harvard School Of Public Health
Same institution · by research overlap
- Stephen Tollman$2,983,655
- Han Chen$3,598,112
- Po-Ru Loh$4,559,642
- Peter Kraft$5,095,658
- Seunggeun Shawn Lee$2,141,943
Others in their field
Top investigators on “Variant”
- Richard A Gibbs · Baylor College Of Medicine$367,607,426
- Richard K. Wilson · Washington University$295,336,569
- Stacey Gabriel · Massachusetts Institute Of Technology$169,231,712
- David Heimbrook · Leidos Biomedical Research, Inc.$125,120,179
- Heidi L Rehm · Broad Institute, Inc.$96,250,516
- Margaret A Pericak-Vance · Doheny Eye Institute$83,999,609
Research focus
VariantGenome Wide Association StudyGenomeGeneticHeritabilityGenotypePhenotypeUntranslated RnaGenesData SetGenome-WideTumorTraitGene ExpressionRisk VariantValidationCancer RiskRegulatory ElementTissuesEpigenomicsQuantitative Trait LociMutationMapsCausal Variant
Grant awards (24)
Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies$1,347,915
R01 · FY2025 · CA
Assessment of germline variants associated with immune-related adverse events following immune checkpoint inhibitors$668,053
R01 · FY2025 · CA
Integrative modelling of single-cell data to elucidate the genetic architecture of complex disease$502,740
R01 · FY2025 · HG · contact PI
Assessment of germline variants associated with immune-related adverse events following immune checkpoint inhibitors$689,934
R01 · FY2024 · CA
Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies$640,260
R01 · FY2024 · CA
Characterizing non-coding somatic and germline variant interactions in ovarian cancer$614,121
R01 · FY2024 · CA
Integrative modelling of single-cell data to elucidate the genetic architecture of complex disease$507,248
R01 · FY2024 · HG · contact PI
Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies$660,477
R01 · FY2023 · CA
Characterizing non-coding somatic and germline variant interactions in ovarian cancer$643,149
R01 · FY2023 · CA
Integrative modelling of single-cell data to elucidate the genetic architecture of complex disease$400,000
R56 · FY2023 · HG · contact PI
(PQ3) A functional genomic approach to identification and interpretation of germline-tumor genetic interactions$699,918
R01 · FY2022 · CA · contact PI
Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies$693,457
R01 · FY2022 · CA
Characterizing non-coding somatic and germline variant interactions in ovarian cancer$663,739
R01 · FY2022 · CA
(PQ3) A functional genomic approach to identification and interpretation of germline-tumor genetic interactions$700,148
R01 · FY2021 · CA · contact PI
Characterizing non-coding somatic and germline variant interactions in ovarian cancer$688,012
R01 · FY2021 · CA
(PQ3) A functional genomic approach to identification and interpretation of germline-tumor genetic interactions$700,797
R01 · FY2020 · CA · contact PI
Characterizing non-coding somatic and germline variant interactions in ovarian cancer$698,082
R01 · FY2020 · CA
Efficient methods for identifying cryptic relatedness in millions of individuals$206,659
R21 · FY2020 · HG · contact PI
(PQ3) A functional genomic approach to identification and interpretation of germline-tumor genetic interactions$667,046
R01 · FY2019 · CA · contact PI
Efficient methods for identifying cryptic relatedness in millions of individuals$165,232
R21 · FY2019 · HG · contact PI
(PQ3) A functional genomic approach to identification and interpretation of germline-tumor genetic interactions$686,519
R01 · FY2018 · CA · contact PI
Fine-mapping heritability at known disease loci with correlated markers$56,042
F32 · FY2015 · GM · contact PI
Fine-mapping heritability at known disease loci with correlated markers$53,282
F32 · FY2014 · GM · contact PI
Fine-mapping heritability at known disease loci with correlated markers$49,214
F32 · FY2013 · GM · contact PI